[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Approvals - August 2005

  ANDA Number Generic Drug Name Applicant Approval Date
1 65-230 CEFTRIAXONE FOR INJECTION USP, 250 MG/VIAL, 500 MG/VIAL, 1 G/VIAL, AND 2 G/VIAL   ORCHID HEALTHCARE 8/2/2005 
2 65-231 CEFTRIAXONE FOR INJECTION USP, 1 G/VIAL AND 2 G/VIAL   ORCHID HEALTHCARE 8/2/2005 
3 65-232 CEFTRIAXONE FOR INJECTION USP, 10 G/VIAL PHARMACY BULK PACKAGE   ORCHID HEALTHCARE 8/2/2005 
4 76-654 HYDROCORTISONE BUTYRATE CREAM USP, 0.1%   TARO PHARMACEUTICAL INDUSTRIES LTD. 8/3/2005 
5 77-171 CLONAZEPAM ORALLY DISINTEGRATING TABLETS, 0.125 MG, 0.25 MG, 0.5 MG, 1 MG, AND 2 MG   KALI LABORATORIES, INC. 8/3/2005 
6 76-868 LOXAPINE CAPSULES USP, 5 MG (BASE), 10 MG (BASE), 25 MG (BASE), AND 50 MG (BASE)   AMIDE PHARMACEUTICAL, INC. 8/4/2005 
7 77-227 HALOBETASOL PROPRIONATE CREAM, 0.05%   TARO PHARMACEUTICALS USA, INC. 8/4/2005 
8 76-977 CLOBETASOL PROPIONATE TOPICAL SOLUTION USP, 0.05%   QLT USA, INC. 8/5/2005 
9 77-092 CICLOPIROX TOPICAL SUSPENSION USP (LOTION), 0.77%   TARO PHARMACEUTICALS USA, INC. 8/10/2005 
10 77-194 CLONAZEPAM ORALLY DISINTEGRATING TABLETS, 0.125 MG, 0.25 MG, 0.5 MG, 1 MG, AND 2 MG   BARR LABORATORIES, INC. 8/10/2005 
11 40-632 METHOTREXATE FOR INJECTION USP (PRESERVATIVE-FREE), 1 GRAM/VIAL   BEDFORD LABORATORIES 8/12/2005 
12 65-242 CLINDAMYCIN HYDROCHLORIDE CAPSULES USP, 75 MG (BASE) AND 150 MG (BASE)   LANNETT HOLDINGS, INC. 8/12/2005 
13 65-243 CLINDAMYCIN HYDROCHLORIDE CAPSULES USP, 300 MG (BASE)   LANNETT HOLDINGS, INC. 8/12/2005 
14 65-244 CEFAZOLIN FOR INJECTION USP, 1 G/VIAL   ORCHID HEALTHCARE 8/12/2005 
15 65-247 CEFAZOLIN FOR INJECTION, 10 GRAM/VIAL (PHARMACY BULK PACKAGE)   ORCHID HEALTHCARE 8/12/2005 
16 76-618 PAROXETINE TABLETS USP, 10 MG , 20 MG , 30 MG, AND 40 MG   TEVA PHARMACEUTICALS USA 8/15/2005 
17 77-144 FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE TABLETS, 10 MG/12.5 MG AND 20 MG/12.5 MG   WATSON LABORATORIES, INC. 8/16/2005 
18 65-234 CEPHALEXIN FOR ORAL SUSPENSION USP, 125 MG/5 ML AND 250 MG/5 ML   LUPIN LIMITED 8/17/2005 
19 76-923 LIOTHYRONINE SODIUM INJECTION, 10 MCG(BASE)/ML; 1 ML VIALS   PHARMAFORCE, INC. 8/17/2005 
20 77-040 CITALOPRAM HYDROBROMIDE TABLETS, 10 MG (BASE), 20 MG (BASE), AND 40 MG (BASE)   SANDOZ INC. 8/17/2005 
21 40-610 PHENYTOIN ORAL SUSPENSION USP, 125 MG/5 ML   VISTAPHARM, INC. 8/18/2005 
22 65-189 AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP, 250 MG/125 MG (BASE)   SANDOZ INC. 8/23/2005 
23 65-224 CEFTRIAXONE INJECTION USP, 1 GRAM/50 ML AND 2 GRAMS/50 ML, PACKAGED IN GALAXY SINGLE-DOSE PLASTIC CONTAINERS   BAXTER HEALTHCARE CORPORATION 8/23/2005 
24 76-736 FLUCONAZOLE INJECTION (IN 0.9% SODIUM CHLORIDE), 2 MG/ML; 100 ML VIALS   HIKMA FARMACEUTICA (PORTUGAL), LDA 8/23/2005 
25 40-570 PREDNISOLONE SYRUP USP, 5 MG/5 ML   APOTEX INC. 8/25/2005 
26 40-571 PREDNISOLONE SYRUP USP, 15 MG/5 ML   APOTEX INC. 8/25/2005 
27 65-136 CLARITHROMYCIN TABLETS USP, 500 MG   SANDOZ INC. 8/25/2005 
28 65-250 CLARITHROMYCIN EXTENDED-RELEASE TABLETS, 500 MG   SANDOZ INC. 8/25/2005 
29 77-203 CHOLESTYRAMINE FOR ORAL SUSPENSION USP, (LIGHT) 4 GRAMS OF RESIN/SCOOPFUL OR PACKET   PAR PHARMACEUTICAL, INC. 8/26/2005 
30 77-204 CHOLESTYRAMINE FOR ORAL SUSPENSION USP, 4 G RESIN/ 9 G SCOOPFUL OR PACKET   PAR PHARMACEUTICAL, INC. 8/26/2005 
31 77-068 BACLOFEN TABLETS USP, 20 MG   VINTAGE PHARMACEUTICALS, LLC 8/30/2005 
32 77-156 BACLOFEN TABLETS USP, 10 MG   VINTAGE PHARMACEUTICALS, LLC 8/30/2005 
33 76-191 FEXOFENADINE HYDROCHLORIDE TABLETS, 30 MG, 60 MG, AND 180 MG   BARR LABORATORIES, INC. 8/31/2005 
34 76-689 MIRTAZAPINE ORALLY DISINTEGRATING TABLETS, 15 MG, 30 MG, AND 45 MG   AMIDE PHARMACEUTICAL, INC. 8/31/2005 

Back to Top      Back to Approvals

Date created: September 15, 2005

horizonal rule